Medical product manufacturer Covidien announced that its Board of Directors has decided to increase the quarterly cash dividend of $0.225 per common share by 16 percent to $0.26 per common share.
“This increase reflects our good performance to date in 2012, our commitment to enhance shareholder value and the Board’s confidence in our future growth prospects,” said José (Joe) E. Almeida, Chairman, President and CEO of Covidien.
At the new rate, the annual dividend is $1.04 per ordinary share, in comparison to the previous rate of $0.90 per ordinary share. The next quarterly dividend is due to be paid on November 5th, to shareholders of record on October 11th, 2012.
[ilink url=“http://investor.covidien.com/phoenix.zhtml?c=207592&p=irol-newsArticle&id=1737143″] Link zur Quelle (Covidien)[/ilink]